Clinical photodynamic therapy for superficial cancer in the oesophagus andthe bronchi: 514 nm compared with 630 nm light irradiation after sensitization with Photofrin II
P. Grosjean et al., Clinical photodynamic therapy for superficial cancer in the oesophagus andthe bronchi: 514 nm compared with 630 nm light irradiation after sensitization with Photofrin II, BR J CANC, 77(11), 1998, pp. 1989-1995
Photodynamic therapy (PDT) for cancer in the oesophagus and bronchi with re
d (630 nm) light may occasionally lead to wall perforation and fistula. The
refore, we investigated the clinical use of a less penetrating wavelength (
514 nm) for the curative treatment of nine superficial carcinomas in the oe
sophagus and bronchi after photosensitization with Photofrin ii. Tumours wi
thout infiltration beyond the submucosa in the oesophagus and beyond the la
mina propria in the bronchi were considered as superficial cancers. The out
come and complications were compared with those of 13 superficial cancers t
reated with PDT and 630 nm light. In addition, we evaluated histologically
the extent of the long-term tissue damage and scarring following treatment
of six oesophageal cancers with either green or red light. At first endosco
pic control, 7-10 days after PDT, tissue necrosis simply matched the illumi
nated area, without evidence of selective tumour damage. Six of nine tumour
s treated with 514 nm light had a complete response compared with nine of 1
3 after 630 nm irradiation. No perforation or fistula occurred in either tr
eatment group. However, severe chest pain and fever with or without pleural
effusion, consistent with occult perforation, were observed in three patie
nts after 630 nm illumination in the oesophagus. Histologically, fibrous sc
arring in the three distinct sites treated with green light was limited to
the superficial layers of the oesophagus. After red light treatment, transm
ural fibrosis with marked thinning of the oesophageal wall was evident in t
wo of the three specimens available for inspection. These results indicate
that PDT with 514 nm light has the potential to cure superficial cancer in
the oesophagus and bronchi with essentially the same probability of success
as red light. In the oesophagus, green light prevents deep tissue damage,
thus reducing the risk of perforation.